About the grant

Clinical trials are important because they’re the primary means of developing new treatments and improving existing ones. Acceptance into a clinical trial can sometimes offer vital access to new drugs. While clinical trials can offer promising treatment options for blood cancer patients, significant hurdles exist, from limited availability and eligibility criteria to practical, financial and social barriers that prevent participation.

For this reason, we have developed clinical improvement grants to support healthcare professionals in improving access to clinical trials.

• Clinical improvement grants are awarded for up to £25,000 for a duration of up to 7 months.
• We're looking to fund up to four projects that aim to make clinical trials more accessible, inclusive, and easier to understand, especially for under-served communities.

We welcome applications for projects that aim to improve barriers people face when it comes to accessing clinical trials. These barriers may be linked to:

• Ethnicity, along with intersecting demographics such as age and gender, and a lack of culturally appropriate support.
• Deprivation and other intersecting socio-economic factors such as education, employment and social support.
• Geography, its intersection with deprivation and practical barriers to accessing healthcare.

Your project might include:

• Rethinking how trial education is delivered to both patients and clinical teams.
• Supporting advocacy efforts that help people better understand and engage with clinical trials.
• Solving practical or logistical challenges patients face when considering trial participation.

This work is kindly supported by the Oglesby Charitable Trust.